Cardiac Manifestation among Children with Hemolytic Uremic Syndrome.


Journal

The Journal of pediatrics
ISSN: 1097-6833
Titre abrégé: J Pediatr
Pays: United States
ID NLM: 0375410

Informations de publication

Date de publication:
Aug 2021
Historique:
received: 29 06 2020
revised: 25 03 2021
accepted: 29 03 2021
pubmed: 6 4 2021
medline: 23 11 2021
entrez: 5 4 2021
Statut: ppublish

Résumé

The primary objectives of the study were to describe the association between cardiac manifestations and in-hospital mortality among children with hemolytic uremic syndrome. Using the Pediatric Health Information System database, this retrospective, multicenter, cohort study identified the first hemolytic uremic syndrome-related inpatient visit among children ≤18 years (years 2004-2018). The frequency of selected cardiac manifestations and mortality rates were calculated. Multivariate analysis identified the association of specific cardiac manifestations and the risk of in-hospital mortality. Among 3915 patients in the analysis, 238 (6.1%) had cardiac manifestations. A majority of patients (82.8%; n = 197) had 1 cardiac condition and 17.2% (n = 41) had ≥2 cardiac conditions. The most common cardiac conditions was pericardial disease (n = 102), followed by congestive heart failure (n = 46) and cardiomyopathy/myocarditis (n = 34). The percent mortality for patients with 0, 1, or ≥2 cardiac conditions was 2.1%, 17.3%, and 19.5%, respectively. Patients with any cardiac condition had an increased odds of mortality (OR, 9.74; P = .0001). In additional models, the presence of ≥2 cardiac conditions (OR, 9.90; P < .001), cardiac arrest (OR, 38.25; P < .001), or extracorporeal membrane oxygenation deployment (OR, 11.61; P < .001) were associated with increased risk of in-hospital mortality. This study identified differences in in-hospital mortality based on the type of cardiac manifestations, with increased risk observed for patients with multiple cardiac involvement, cardiac arrest, and extracorporeal membrane oxygenation deployments.

Identifiants

pubmed: 33819463
pii: S0022-3476(21)00316-4
doi: 10.1016/j.jpeds.2021.03.067
pmc: PMC8316308
mid: NIHMS1701179
pii:
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

144-148.e4

Subventions

Organisme : NCATS NIH HHS
ID : UL1 TR003107
Pays : United States

Informations de copyright

Copyright © 2021 Elsevier Inc. All rights reserved.

Références

Pediatr Nephrol. 2013 Nov;28(11):2097-105
pubmed: 23288350
Pediatr Nephrol. 1994 Dec;8(6):754-5
pubmed: 7696120
Pediatr Nephrol. 1997 Apr;11(2):221-2
pubmed: 9090671
Nephrol Dial Transplant. 2009 Feb;24(2):679-81
pubmed: 19033247
J Pediatr Intensive Care. 2020 Dec;9(4):290-294
pubmed: 33133747
Pediatrics. 2006 May;117(5):1656-62
pubmed: 16651320
Clin Infect Dis. 2017 Jun 15;64(12):1637-1643
pubmed: 28329394
Clin Infect Dis. 2009 Nov 15;49(10):1480-5
pubmed: 19827953
Eur J Pediatr. 2016 Dec;175(12):1927-1931
pubmed: 27659663
J AHIMA. 2004 Nov-Dec;75(10):22-6
pubmed: 15559835
Pediatr Cardiol. 2005 Jan-Feb;26(1):104-6
pubmed: 15136901
J Pediatr. 1964 Apr;64:478-91
pubmed: 14141006
Pediatr Nephrol. 2017 Nov;32(11):2155-2158
pubmed: 28780656
Paediatr Anaesth. 2007 Jun;17(6):584-7
pubmed: 17498023
Pediatr Nephrol. 2003 Mar;18(3):286-9
pubmed: 12644926
Arch Dis Child. 1995 Jan;72(1):46-7
pubmed: 7717737
Nephrol Dial Transplant. 1998 Sep;13(9):2419-20
pubmed: 9761544
Pediatr Nephrol. 1995 Feb;9(1):117-9
pubmed: 7742210
J Pediatr. 2015 Apr;166(4):1022-9
pubmed: 25661408
Am J Med. 2005 May;118(5):544-7
pubmed: 15866258
Am J Dis Child. 1971 Nov;122(5):418-20
pubmed: 4943015
Br Heart J. 1987 Feb;57(2):181-3
pubmed: 3814452
Curr Opin Pediatr. 2005 Apr;17(2):200-4
pubmed: 15800412

Auteurs

Emily Sanders (E)

Division of Pediatrics, University of Arkansas for Medical Sciences, Arkansas Children's Hospital, Little Rock, AR.

Clare C Brown (CC)

Department of Health Policy and Management, Fay W. Boozman College of Public Health, University of Arkansas for Medical Sciences, Little Rock, AR.

Richard T Blaszak (RT)

Division of Nephrology, Department of Pediatrics, University of Arkansas for Medical Sciences, Arkansas Children's Hospital, Little Rock, AR.

Brendan Crawford (B)

Division of Nephrology, Department of Pediatrics, University of Arkansas for Medical Sciences, Arkansas Children's Hospital, Little Rock, AR.

Parthak Prodhan (P)

Division of Nephrology, Department of Pediatrics, University of Arkansas for Medical Sciences, Arkansas Children's Hospital, Little Rock, AR; Division of Pediatric Cardiology/Pediatric Critical Care, University of Arkansas for Medical Sciences, Arkansas Children's Hospital, Little Rock, AR.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH